Table 1 Hematological parameters in study population
Age | Parameters normal range | % below range | % within range | % above range |
|---|---|---|---|---|
RBCs*(10^6/μl) | ||||
0 to 3 months | 2.8–4.8 | 0 | 80 | 20 |
4–12 months | 3.2–5.2 | 0 | 80 | 20 |
1–3 years | 3.6–5.2 | 0 | 100 | 0 |
4–11 years | 3.7–5.8 | 0 | 88 | 12 |
12–14 years | 4.0–5.8 | 0 | 100 | 0 |
WBCs*(10^3/μl) | ||||
0 to 2 months | 5.5–18 | 0 | 80 | 20 |
3–12 months | 6–17.5 | 0 | 91 | 9 |
1–3 years | 6–17 | 0 | 75 | 25 |
4–5 years | 5–15.5 | 33.3 | 33.3 | 33.3 |
6–11 years | 4.5–13.5 | 0 | 100 | 0 |
12–14 years | 4–11 | 0 | 66.6 | 33.3 |
Hemoglobin (g/dl) | ||||
0 to 3 months | 9.6–13.6 | 30 | 60 | 10 |
4–9 months | 10.1–12.9 | 40 | 53.3 | 6.6 |
10 months–3 years | 10.7–13.1 | 35.2 | 64.7 | 0 |
4–7 years | 10.7–14.7 | 0 | 83.3 | 16.6 |
8–11 years | 10.8–15.6 | 0 | 100 | 0 |
12–14 years | 11.5–16 | 33.3 | 66.6 | 0 |
Others | ||||
Platelets*(10^3/μl) | 200–550 | 5.66 | 77.3 | 16.9 |
Prothrombin time PT (SEC) | 9–14 | 5.66 | 92.4 | 1.88 |
Activated partial thromboplastin time APTT (SEC) | 22–31 | 1.88 | 90.5 | 7.54 |